Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/08/2009WO2009123776A2 Antiviral drugs for treatment of arenavirus infection
10/08/2009WO2009123761A1 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/08/2009WO2009123742A1 Use of ribose in first response to acute myocardial infarction
10/08/2009WO2009123714A2 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
10/08/2009WO2009123623A1 Di-fluoro containing compounds as cysteine protease inhibitors
10/08/2009WO2009123597A1 Pharmaceutical composition
10/08/2009WO2009123595A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
10/08/2009WO2009123588A1 Amides of 3, 5-substituted-is0xaz0le-4-carb0xylic acids for the treatment of viral infections, cancer and restenosis
10/08/2009WO2009123580A1 Chewable tablet and method of formulating
10/08/2009WO2009123575A1 A photosensitising composition and its uses
10/08/2009WO2009123569A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
10/08/2009WO2009123537A1 GABAa RECEPTOR MODULATORS
10/08/2009WO2009123536A1 NEW CLASSES OF GABAa/BZR LIGANDS
10/08/2009WO2009123487A1 Compounds for treating pain
10/08/2009WO2009123486A1 Use of compounds in the treatment of tau-induced cytotoxicities
10/08/2009WO2009123481A1 Compositions and methods for treatment of neoplastic disease
10/08/2009WO2009123480A1 Anti-infective agents and uses thereof
10/08/2009WO2009123457A2 Compositions and methods for treating sweet itch
10/08/2009WO2009123364A1 Mineral absorption accelerator and iron deficiency anemia improver or food composition
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123304A1 Fine granules having improved suspension performance in water
10/08/2009WO2009123257A1 Soft capsule coating and soft capsule
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009WO2009123216A1 Novel dna capable of being amplified by pcr with high selectivity and high efficiency
10/08/2009WO2009123215A1 Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method
10/08/2009WO2009123210A1 Preventive and/or remedy for vascular diseases
10/08/2009WO2009123207A1 Oral rinse composition
10/08/2009WO2009123206A1 Oral pharmaceutical composition
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009123185A1 Double-stranded lipid-modified rna having high rna interference effect
10/08/2009WO2009123183A1 Antiviral agent and antiviral composition
10/08/2009WO2009123169A1 Amide derivative-containing pharmaceutical composition
10/08/2009WO2009123164A1 Heterocyclic derivative having inhibitory activity on endothelial lipase
10/08/2009WO2009123102A1 Processed starch powder with excellent disintegration properties and manufacturing method thereof
10/08/2009WO2009123099A1 Aqueous liquid containing gatifloxacin
10/08/2009WO2009123098A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
10/08/2009WO2009123080A1 Indolinone compound
10/08/2009WO2009123029A1 Blood ammonia level regulator
10/08/2009WO2009122983A1 Ketone accumulation inhibitor
10/08/2009WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases
10/08/2009WO2009122707A1 1,3-dihydroisobenzofuran derivative
10/08/2009WO2009122667A1 Therapeutic for hepatic cancer
10/08/2009WO2009122447A1 Semi-synthetic sesquiterpene lactone parthenin compound useful for cytotoxicity against cancer cell lines and anticander agent
10/08/2009WO2009122435A2 A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
10/08/2009WO2009122425A1 Novel crystalline form of carvedilol dihydrogen phosphate and related processes
10/08/2009WO2009122400A1 Phosphate binding polymers
10/08/2009WO2009122337A1 Process for extracting active components from lippia polystachya and extract thus obtained
10/08/2009WO2009122301A2 Rasagiline mesylate particles and process for the preparation thereof
10/08/2009WO2009122183A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122182A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122181A1 New combination for use in the treatment of inflammatory disorders
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122176A2 Rapamycin carbonate esters
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009WO2009122045A2 Use of olive oil extract to control skin aging
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121993A1 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof
10/08/2009WO2009121959A1 Use of glycosaminoglycan for restoring glycocalyx
10/08/2009WO2009121957A1 Toltrazuril with improved dissolution properties
10/08/2009WO2009121940A1 Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester
10/08/2009WO2009121939A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009WO2009121935A2 Pharmaceutical composition with bisphosphonate
10/08/2009WO2009121929A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder.
10/08/2009WO2009121919A1 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/08/2009WO2009121914A1 Substituted piperidines as therapeutic compounds
10/08/2009WO2009121910A1 Indene derivatives as estrogen receptor ligands
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2009121871A1 Pharmaceutical composition comprising candesartan
10/08/2009WO2009121812A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
10/08/2009WO2009121741A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009121740A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009121687A1 L-citrulline for treating endothelial dysfunction and erectile dysfunction
10/08/2009WO2009121629A1 Solubilisation method
10/08/2009WO2009121623A2 Compounds for treating muscular dystrophy
10/08/2009WO2009121600A2 Hydroxytyrosol formulations for the treatment and prevention of dna oxidative damages in post-menopausal conditions
10/08/2009WO2009121585A1 Pharmaceutical preparation comprising permethylated cyclodextrin
10/08/2009WO2009121535A2 Antiproliferative compounds and therapeutic uses thereof
10/08/2009WO2009121519A1 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
10/08/2009WO2009121303A1 Pharmaceutically acceptable salts of anti-infective quinolone compound
10/08/2009WO2009121245A1 Fostriecin derivatives and the pharmaceutical uses thereof
10/08/2009WO2009121238A1 A composition and method for auto-treating tumors
10/08/2009WO2009121228A2 A lubiprostone crystal, its preparation process and its use
10/08/2009WO2009121218A1 The use of mercurid in formulating antiviral medicine
10/08/2009WO2009121183A1 Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
10/08/2009WO2009121178A1 Novel oral controlled release pharmaceutical formulations
10/08/2009WO2009121155A2 Use of one or more benzopyranones, phamaceutical composmon and method for preventing or treating diseases, dysfunctions and disturbances associated to monoamine oxidase
10/08/2009WO2009102488A3 A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
10/08/2009WO2009100435A3 Sclerotherapy for varicose veins
10/08/2009WO2009100330A3 Platinum aggregates and process for producing the same
10/08/2009WO2009098612A3 Polymorphic form of a [1, 2, 4] triazolo [4, 3-a] pyridine derivative for treating inflammatory diseases
10/08/2009WO2009097351A9 TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs
10/08/2009WO2009095792A3 Substituted heteroarylamide diazepinopyrimidone derivatives
10/08/2009WO2009094456A3 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
10/08/2009WO2009093210A3 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
10/08/2009WO2009093209A3 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
10/08/2009WO2009091932A3 Treatment of mild dementia of the alzheimer's disease type
10/08/2009WO2009089399A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection
10/08/2009WO2009089234A3 Substituted dibenzhydrylpiperazines
10/08/2009WO2009088838A3 Triarylmethane analogs and their use in treating cancers
1 ... 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 ... 7860